Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Effect of desipramine treatment on 3H-imipramine binding in the blood platelets of depressed patients.

Arora RC, Meltzer HY.

Biol Psychiatry. 1988 Feb 15;23(4):397-404. Review.

PMID:
3277675
2.

Platelet 3H-imipramine binding: a state-dependent marker in depression.

Suranyi-Cadotte B, Quirion R, McQuade P, Nair NP, Schwartz G, Mosticyan S, Wood PL.

Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(4-6):737-41.

PMID:
6531445
3.

Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.

Lawrence KM, Falkowski J, Jacobson RR, Horton RW.

Psychopharmacology (Berl). 1993;110(1-2):235-9.

PMID:
7870891
4.

Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.

Wgner A, Montero D, MÃ¥rtensson B, Siwers B, Asberg M.

J Affect Disord. 1990 Oct;20(2):101-13.

PMID:
2176228
5.

Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.

Arora RC, Wunnicke V, Meltzer HY.

Biol Psychiatry. 1985 Jan;20(1):116-9.

PMID:
2981127
6.

Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.

Poirier MF, Benkelfat C, Loo H, Sechter D, Zarifian E, Galzin AM, Langer SZ.

Psychopharmacology (Berl). 1986;89(4):456-61.

PMID:
3092276
7.

Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.

DeMet EM, Gerner RH, Bell KM, Kauffmann CD, Chicz-DeMet A, Warren S.

Biol Psychiatry. 1989 Sep;26(5):478-88.

PMID:
2551399
8.

High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.

Raisman R, Sechter D, Briley MS, Zarifian E, Langer SZ.

Psychopharmacology (Berl). 1981;75(4):368-71.

PMID:
6803282
9.

Effect of membrane protein concentration on binding of 3H-imipramine in human platelets.

Barkai AI, Kowalik S, Baron M.

Biol Psychiatry. 1985 Feb;20(2):215-9.

PMID:
3971002
10.
11.

3H-imipramine binding in depressed elderly: relationship to family history and clinical response.

Schneider LS, Fredrickson ER, Severson JA, Sloane RB.

Psychiatry Res. 1986 Dec;19(4):257-66.

PMID:
3809324
12.

Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.

Werstiuk ES, Auffarth SE, Coote M, Gupta RN, Steiner M.

Pharmacopsychiatry. 1992 Jul;25(4):199-206.

PMID:
1326772
13.

[3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].

Zarifian E, Sechter D, Bouchami F, Cuche H, Olie JP, Susini JR, Loo H, Briley M, Raisman R, Langer SZ.

Nouv Presse Med. 1982 Apr 17;11(18):1385-7. French.

PMID:
7079155
15.
16.

Platelet 3H-imipramine binding and response to minaprine in patients with major depression.

Maj M, Mastronardi P, Palomba U, Romano M, Ventra C, Kemali D.

Pharmacopsychiatry. 1988 Mar;21(2):101-3.

PMID:
3393597
17.

Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.

Piletz JE, Halaris A, Nelson J, Qu Y, Bari M.

J Psychiatr Res. 1996 May-Jun;30(3):147-68.

PMID:
8884655
18.

Imipramine binding sites on platelets of patients with major depressive disorder.

Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, Taljaard JJ.

Psychiatry Res. 1986 Aug;18(4):333-42.

PMID:
3018818
19.

High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.

Marazziti D, Perugi G, Deltito J, Lenzi A, Maremmani I, Placidi GF, Cassano GB.

Psychiatry Res. 1988 Feb;23(2):229-37.

PMID:
2834766
20.

Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.

Hrdina PD, Lapierre YD, Horn ER, Bakish D.

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):619-23.

PMID:
3003804
Items per page

Supplemental Content

Write to the Help Desk